Natural selenium particles from Staphylococcus carnosus: Hazards or particles with particular promise? EC Estevam, S Griffin, MJ Nasim, P Denezhkin, R Schneider, R Lilischkis, ... Journal of hazardous materials 324, 22-30, 2017 | 67 | 2017 |
Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2, 5-dioxopyrrolidin-1-yl) propanamides and 2-(2, 5-dioxopyrrolidin-1-yl) butanamides K Kamiński, M Zagaja, JJ Łuszczki, A Rapacz, M Andres-Mach, G Latacz, ... Journal of medicinal chemistry 58 (13), 5274-5286, 2015 | 59 | 2015 |
Novel multitarget-directed ligands aiming at symptoms and causes of Alzheimer’s disease A Więckowska, T Wichur, J Godyń, A Bucki, M Marcinkowska, A Siwek, ... ACS chemical neuroscience 9 (5), 1195-1214, 2018 | 57 | 2018 |
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2, 5-dioxopyrrolidin-1-yl) propanamide and 2-(2, 5-dioxopyrrolidin-1-yl … K Kamiński, A Rapacz, JJ Łuszczki, G Latacz, J Obniska, ... Bioorganic & medicinal chemistry 23 (10), 2548-2561, 2015 | 56 | 2015 |
Aryl-1, 3, 5-triazine derivatives as histamine H4 receptor ligands D Łażewska, M Więcek, J Ner, K Kamińska, T Kottke, JS Schwed, ... European journal of medicinal chemistry 83, 534-546, 2014 | 52 | 2014 |
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction T Felicetti, R Cannalire, D Pietrella, G Latacz, A Lubelska, G Manfroni, ... Journal of medicinal chemistry 61 (17), 7827-7848, 2018 | 47 | 2018 |
The 1, 3, 5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, MA Marć, ... International Journal of Molecular Sciences 20 (14), 3420, 2019 | 45 | 2019 |
In the search for a lead structure among series of potent and selective hydantoin 5‐HT7R agents: The drug‐likeness in vitro study G Latacz, A Lubelska, M Jastrzębska‐Więsek, A Partyka, A Sobiło, ... Chemical biology & drug design 90 (6), 1295-1306, 2017 | 45 | 2017 |
Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse K Popiolek‐Barczyk, D Łażewska, G Latacz, A Olejarz, W Makuch, H Stark, ... British journal of pharmacology 175 (14), 2897-2910, 2018 | 43 | 2018 |
KA-11, a novel pyrrolidine-2, 5-dione derived broad-spectrum anticonvulsant: its antiepileptogenic, antinociceptive properties and in vitro characterization K Socała, S Mogilski, M Pieróg, D Nieoczym, M Abram, B Szulczyk, ... ACS chemical neuroscience 10 (1), 636-648, 2018 | 39 | 2018 |
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, K Kucwaj-Brysz, ... Bioorganic & medicinal chemistry letters 28 (5), 878-883, 2018 | 39 | 2018 |
Chlorophenoxy aminoalkyl derivatives as histamine H3R ligands and antiseizure agents K Kuder, D Łażewska, G Latacz, JS Schwed, T Karcz, H Stark, ... Bioorganic & medicinal chemistry 24 (2), 53-72, 2016 | 39 | 2016 |
Multifunctional hybrid compounds derived from 2-(2, 5-dioxopyrrolidin-1-yl)-3-methoxypropanamides with anticonvulsant and antinociceptive properties M Abram, M Zagaja, S Mogilski, M Andres-Mach, G Latacz, S Baś, ... Journal of medicinal chemistry 60 (20), 8565-8579, 2017 | 34 | 2017 |
The study of cellular cytotoxicity of argireline-an anti-aging peptide. M Grosicki, G Latacz, A Szopa, A Cukier, K Kieć-Kononowicz Acta Biochimica Polonica 61 (1), 2014 | 34 | 2014 |
Selenazolinium salts as “small molecule catalysts” with high potency against ESKAPE bacterial pathogens K Witek, M Nasim, M Bischoff, R Gaupp, P Arsenyan, J Vasiljeva, M Marć, ... Molecules 22 (12), 2174, 2017 | 33 | 2017 |
Aspects of a distinct cytotoxicity of selenium salts and organic selenides in living cells with possible implications for drug design E Estevam, K Witek, L Faulstich, M Nasim, G Latacz, ... Molecules 20 (8), 13894-13912, 2015 | 33 | 2015 |
Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1 H-imidazol-5-yl)-1 H-indole-5-carboxamides, low-basicity 5-HT 7 … G Latacz, AS Hogendorf, A Hogendorf, A Lubelska, JM Wierońska, ... MedChemComm 9 (11), 1882-1890, 2018 | 31 | 2018 |
Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands K Szczepańska, T Karcz, S Mogilski, A Siwek, KJ Kuder, G Latacz, ... European journal of medicinal chemistry 152, 223-234, 2018 | 30 | 2018 |
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats B Sadek, A Saad, G Latacz, K Kuder, A Olejarz, T Karcz, H Stark, ... Drug design, development and therapy 10, 3879, 2016 | 30 | 2016 |
Novel naphthyloxy derivatives–potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation D Łażewska, M Kaleta, S Hagenow, S Mogilski, G Latacz, T Karcz, ... Bioorganic & medicinal chemistry 26 (9), 2573-2585, 2018 | 29 | 2018 |